Bloxiverz
NDC Package 76014-902-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bloxiverz is a . Marketed by Avadel Legacy Pharmaceuticals, Llc, this product is identified by NDC 76014-902 and is authorized under FDA application NDA204078.

Identification & Billing

NDC Package Code
76014-902-10
Package Description
10 CARTON in 1 PACKAGE / 1 VIAL, MULTI-DOSE in 1 CARTON (76014-902-33) / 10 mL in 1 VIAL, MULTI-DOSE
Product Code
76014-902
11-Digit Billing Format
76014090210
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Bloxiverz
Dosage Form
-

Regulatory & Marketing

Labeler Name
Avadel Legacy Pharmaceuticals, Llc
FDA Application #
NDA204078
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-24-2013
End Marketing Date
12-31-2018
Listing Expiration
12-31-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76014-902-10 identifies a specific commercial package of 10 carton in 1 package / 1 vial, multi-dose in 1 carton (76014-902-33) / 10 ml in 1 vial, multi-dose of Bloxiverz, labeled by Avadel Legacy Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Avadel Legacy Pharmaceuticals, Llc on July 24, 2013. The current certification is valid through December 31, 2018.

How is this Avadel Legacy Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76014090210. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76014-902-10
11-Digit CMS (5-4-2)
76014-0902-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.